Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus
Overview
Chemistry
Molecular Biology
Affiliations
Numerous studies have shown that oxidative stress resulting from an imbalance between the production of free radicals and their neutralization by antioxidant enzymes is one of the major pathological disorders underlying the development and progression of type 2 diabetes (T2D). The present review summarizes the current state of the art advances in understanding the role of abnormal redox homeostasis in the molecular mechanisms of T2D and provides comprehensive information on the characteristics and biological functions of antioxidant and oxidative enzymes, as well as discusses genetic studies conducted so far in order to investigate the contribution of polymorphisms in genes encoding redox state-regulating enzymes to the disease pathogenesis.
Hu D, Li Y, Li R, Wang M, Zhou K, He C Acta Pharm Sin B. 2025; 14(12):5106-5131.
PMID: 39807318 PMC: 11725102. DOI: 10.1016/j.apsb.2024.10.015.
Shokat S, Iqbal R, Ali M, Yaqub A, Aslam S, Riaz S Biol Trace Elem Res. 2024; .
PMID: 39699707 DOI: 10.1007/s12011-024-04448-2.
NADPH oxidase 5 is a novel susceptibility gene for type 2 diabetes mellitus.
Azarova I, Klyosova E, Azarova V, Polonikov A Arch Endocrinol Metab. 2024; 68:e230527.
PMID: 39529984 PMC: 11554360. DOI: 10.20945/2359-4292-2023-0527.
Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases.
Dragoi C, Diaconu C, Nicolae A, Dumitrescu I Antioxidants (Basel). 2024; 13(10).
PMID: 39456418 PMC: 11504313. DOI: 10.3390/antiox13101163.
Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.
Naja K, Anwardeen N, Bashraheel S, Elrayess M J Pharm Pharm Sci. 2024; 27:13305.
PMID: 39355646 PMC: 11442225. DOI: 10.3389/jpps.2024.13305.